お知らせ • Mar 01
Evolve Transition Infrastructure Files Form 15 Evolve Transition Infrastructure LP has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its Common Units under the Securities Exchange Act of 1934, as amended. お知らせ • Jan 09
Evolve Transition Infrastructure Intends to Withdraw Voluntarily its Common Units from Listing on the New York Stock Exchange On January 8, 2024, Evolve Transition Infrastructure GP LLC (the “General Partner”), the general partner of Evolve Transition Infrastructure LP (the “Partnership”), elected to exercise its right as the holder (together with its controlled affiliates) of more than 80% of the outstanding Common Units and pursuant to Section 15.1 of the Partnership’s Third Amended and Restated Agreement of Limited Partnership, as amended (the “Partnership Agreement”) to purchase all of the issued and outstanding common units representing limited partner interests in the Partnership (“Common Units”) not already owned by the General Partner or its controlled affiliates for a cash purchase price, determined pursuant to the contractual formula set in Section 15.1(b) of the Partnership Agreement, of $1.389285 per unit (the “Purchase Right”). As a result of the purchase, the General Partner and its affiliates will own, directly or indirectly 100% of the Partnership’s Common Units and there will no longer be a public market for the Common Units. Therefore, the Partnership intends to withdraw voluntarily its Common Units from listing on the New York Stock Exchange and from registration on the NYSE American under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and to file a Form 25 with the Securities and Exchange Commission (the “SEC”) to withdraw voluntarily the Common Units from listing on the NYSE American and from registration on the NYSE American under Section 12(b) of the Exchange Act. The Partnership expects that the Common Units will continue to be listed through February 16, 2024 and will no longer be listed on February 19, 2024. お知らせ • Jul 27
Evolve Transition Announces NYSE American Removal of Trading Suspension Evolve Transition Infrastructure LP announced that on July 25, 2023, it received a letter from NYSE American LLC informing Evolve that it has resolved the continued listing deficiency with respect to low selling price as described in Section 1003(f)(v) of the NYSE American Company Guide. As a result, the staff of NYSE Regulation has withdrawn its delisting determination and will be lifting the trading suspension on the Partnership’s common units representing limited partner interests in the Partnership on the NYSE American. The common units will commence trading on the NYSE American on Monday, July 31, 2023 under the symbol “SNMP.” Notwithstanding the lifting of the trading suspension, Evolve continues to remain subject to its previously disclosed plan to regain compliance with the NYSE American’s continued listing standards, which was accepted by the NYSE American on February 21, 2023. As noted in its February 23, 2023 press release, Evolve has been granted a target completion date of June 6, 2024 to implement its plan and regain compliance with the NYSE American’s continued listing standards set forth in Sections 1003(a)(i) and 1003(a)(ii) of the Company Guide. If the Partnership is not in compliance with the continued listing standards by June 6, 2024, or if it does not make progress consistent with the plan during the plan period, the NYSE American may again initiate delisting proceedings as appropriate. The Partnership intends to regain compliance with the NYSE American’s continued listings standards by such date; however, there is no assurance the Partnership will be able to accomplish this. お知らせ • Jun 30
Evolve Transition Infrastructure Receives Notice from NYSE Office of General Counsel Confirming A Listing Qualifications Panel of the Committee for Review As previously disclosed, Evolve Transition Infrastructure LP (the Partnership") received notice on June 6, 2023 from the NYSE American LLC (NYSE") that the Partnership was not in compliance with the continued listing standards set in Section 1003(f)(v) of the NYSE American Company Guide and disclosed that NYSE Regulation has determined to commence proceedings to delist the Partnership's common units representing limited partner interests in the Partnership (Common Units") from the NYSE due to the low selling price of the Common Units. On June 13, 2023, the Partnership submitted formal written notice exercising its right to a review of NYSE Regulation's delisting determination in accordance with the NYSE delisting procedures and awaits an oral hearing regarding the Partnership's continued listing. On June 23, 2023, the Partnership received notice from the NYSE Office of General Counsel confirming that, in accordance with the NYSE Company Guide, a Listing Qualifications Panel of the Committee for Review (the Panel") has been authorized to make a determination on this matter and the hearing before the Panel is scheduled for August 8, 2023. As previously disclosed, the delisting of the Common Units will be stayed pending the conclusion of the review process, while the trading suspension that was implemented on June 6, 2023 will remain in effect. If the Partnership is successful in its appeal of NYSE Regulation's determination to commence delisting proceedings, the Common Units may resume trading on the NYSE. In the interim, the Common Units will continue to trade on the over-the-counter market under the symbol SNMP." As previously disclosed, the Partnership announced a one-for-thirty reverse split (the Reverse Split") of its Common Units on May 22, 2023 and later amended the date for the previously announced Reverse Split due to the fact that the Reverse Split was subject to review by the Financial Industry Regulatory Authority (FINRA") as a result of the Common Units initiating trading on the over-the-counter market on June 7, 2023. On June 23, 2023, the Partnership issued a press release announcing that it is amending the date for the previously announced Reverse Split to be effective after the over-the-counter market closes on July 17, 2023. The Common Units will begin trading on a split-adjusted basis when the over-the-counter market opens on July 18, 2023. The Common Units will continue trading on the over-the-counter market under the symbol SNMP" and will be assigned a new CUSIP number (30053M203) following the Reverse Split. お知らせ • Jun 16
Evolve Transition Infrastructure Submits Formal Written Notice Exercising Its Right to A Review of NYSE Regulation’s Delisting Determination As previously disclosed, Evolve Transition Infrastructure LP (the “Partnership”) received notice on June 6, 2023 from the NYSE American LLC (“NYSE”) that the Partnership was not in compliance with the continued listing standards set forth in Section 1003(f)(v) of the NYSE American Company Guide and disclosed that NYSE Regulation has determined to commence proceedings to delist the Partnership’s common units representing limited partner interests in the Partnership (“Common Units”) from the NYSE due to the low selling price of the Common Units. On June 13, 2023, the Partnership submitted formal written notice exercising its right to a review of NYSE Regulation’s delisting determination in accordance with the NYSE delisting procedures and awaits an oral hearing regarding the Partnership’s continued listing. The delisting of the Common Units will be stayed pending the conclusion of the review process, while the trading suspension that was implemented on June 6, 2023 will remain in effect. If the Partnership is successful in its appeal of NYSE Regulation’s determination to commence delisting proceedings, the Common Units may resume trading on the NYSE. In the interim, the Common Units will continue to trade on the over-the-counter market. New Risk • Jun 08
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: US$6.80m This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (21% average weekly change). Earnings have declined by 34% per year over the past 5 years. Shareholders have been substantially diluted in the past year (57% increase in shares outstanding). Market cap is less than US$10m (US$6.80m market cap). Minor Risk Negative equity (-US$243m). 
